Numis Securities Ltd Reaffirms Add Rating for Hvivo PLC (HVO)

Numis Securities Ltd reiterated their add rating on shares of Hvivo PLC (LON:HVO) in a research note published on Thursday morning. They currently have a GBX 210 ($2.74) target price on the stock.

Hvivo PLC (LON:HVO) opened at 185.00 on Thursday. Hvivo PLC has a 52-week low of GBX 167.00 and a 52-week high of GBX 285.00. The firm has a 50 day moving average of GBX 180.04 and a 200-day moving average of GBX 186.41. The stock’s market cap is GBX 144.42 million.

In related news, insider Ellertson,Jaime bought 7,801 shares of the business’s stock in a transaction that occurred on Wednesday, August 3rd. The stock was bought at an average cost of GBX 187 ($2.44) per share, with a total value of £14,587.87 ($19,041.73).

About Hvivo PLC

hVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold.

Receive News & Ratings for Hvivo PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hvivo PLC and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.